These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 25525198)

  • 1. Exploring the epidemiology of carbapenem-resistant Gram-negative bacteria in west London and the utility of routinely collected hospital microbiology data.
    Freeman R; Moore LS; Charlett A; Donaldson H; Holmes AH
    J Antimicrob Chemother; 2015 Apr; 70(4):1212-8. PubMed ID: 25525198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular characterization and risk factors for carbapenem-resistant Gram-negative bacilli colonization in children: emergence of NDM-producing Acinetobacter baumannii in a newborn intensive care unit in Turkey.
    Karaaslan A; Soysal A; Altinkanat Gelmez G; Kepenekli Kadayifci E; Söyletir G; Bakir M
    J Hosp Infect; 2016 Jan; 92(1):67-72. PubMed ID: 26601601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and molecular epidemiology of intestinal colonization by carbapenem-resistant Gram-negative bacteria in patients with hematological diseases: a multicenter case‒control study.
    Hu H; Wang Y; Sun J; Wang Y; Zhou J; Shi Q; Han X; Jiang Y; Wu D; Huang X; Yu Y
    Microbiol Spectr; 2024 Jul; 12(7):e0429923. PubMed ID: 38847538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
    Katchanov J; Asar L; Klupp EM; Both A; Rothe C; König C; Rohde H; Kluge S; Maurer FP
    PLoS One; 2018; 13(4):e0195757. PubMed ID: 29649276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of diverse carbapenem and multidrug resistance genes and high-risk strain types among carbapenem non-susceptible clinical isolates of target gram-negative bacteria in Kenya.
    Musila L; Kyany'a C; Maybank R; Stam J; Oundo V; Sang W
    PLoS One; 2021; 16(2):e0246937. PubMed ID: 33617559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbapenem-resistant Gram-negative bacilli in Canada 2009-10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP).
    Mataseje LF; Bryce E; Roscoe D; Boyd DA; Embree J; Gravel D; Katz K; Kibsey P; Kuhn M; Mounchili A; Simor A; Taylor G; Thomas E; Turgeon N; Mulvey MR;
    J Antimicrob Chemother; 2012 Jun; 67(6):1359-67. PubMed ID: 22398651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of carbapenem-resistant Gram-negative infections globally.
    Brink AJ
    Curr Opin Infect Dis; 2019 Dec; 32(6):609-616. PubMed ID: 31567571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.
    Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
    Antimicrob Resist Infect Control; 2018; 7():137. PubMed ID: 30479750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic consumption versus the prevalence of carbapenem-resistant Gram-negative bacteria at a tertiary hospital in China from 2011 to 2017.
    Zhang D; Hu S; Sun J; Zhang L; Dong H; Feng W; Lei J; Dong Y
    J Infect Public Health; 2019; 12(2):195-199. PubMed ID: 30385238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals.
    Falagas ME; Skalidis T; Vardakas KZ; Legakis NJ;
    J Antimicrob Chemother; 2017 Jun; 72(6):1704-1708. PubMed ID: 28369471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis.
    Righi E; Peri AM; Harris PN; Wailan AM; Liborio M; Lane SW; Paterson DL
    J Antimicrob Chemother; 2017 Mar; 72(3):668-677. PubMed ID: 27999023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbapenem susceptibilities and non-susceptibility concordance to different carbapenems amongst clinically important Gram-negative bacteria isolated from intensive care units in Taiwan: results from the Surveillance of Multicentre Antimicrobial Resistance in Taiwan (SMART) in 2009.
    Jean SS; Hsueh PR; Lee WS; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Lam C; Chen RJ
    Int J Antimicrob Agents; 2013 May; 41(5):457-62. PubMed ID: 23507415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance phenotypes and genotypes in Mexico in representative gram-negative species: Results from the infivar network.
    Garza-González E; Bocanegra-Ibarias P; Bobadilla-Del-Valle M; Ponce-de-León-Garduño LA; Esteban-Kenel V; Silva-Sánchez J; Garza-Ramos U; Barrios-Camacho H; López-Jácome LE; Colin-Castro CA; Franco-Cendejas R; Flores-Treviño S; Morfín-Otero R; Rojas-Larios F; Mena-Ramírez JP; Fong-Camargo MG; Morales-De-la-Peña CT; García-Mendoza L; Choy-Chang EV; Aviles-Benitez LK; Feliciano-Guzmán JM; López-Gutiérrez E; Gil-Veloz M; Barajas-Magallón JM; Aguirre-Burciaga E; López-Moreno LI; Martínez-Villarreal RT; Canizales-Oviedo JL; Cetina-Umaña CM; Romero-Romero D; Bello-Pazos FD; Barlandas-Rendón NRE; Maldonado-Anicacio JY; Bolado-Martínez E; Galindo-Méndez M; Perez-Vicelis T; Alavez-Ramírez N; Méndez-Sotelo BJ; Cabriales-Zavala JF; Nava-Pacheco YC; Moreno-Méndez MI; García-Romo R; Silva-Gamiño AR; Avalos-Aguilera AM; Santiago-Calderón MA; López-García M; Velázquez-Acosta MDC; Cobos-Canul DI; Vázquez-Larios MDR; Ortiz-Porcayo AE; Guerrero-Núñez AE; Valero-Guzmán J; Rosales-García AA; Ostos-Cantú HL; Camacho-Ortiz A
    PLoS One; 2021; 16(3):e0248614. PubMed ID: 33730101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of microscan walkaway 96 plus ID/AST system and mikrolatest broth microdilution kit in assessing
    Singh RI; Bhatia M; Anusha KR; Singh V; Omar BJ; Gupta P
    Indian J Med Microbiol; 2019; 37(4):502-508. PubMed ID: 32436871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and Genotypic Characterization of Carbapenem-Resistant Gram-Negative Bacilli Pathogens from Hospitals in Ghana.
    Codjoe FS; Donkor ES; Smith TJ; Miller K
    Microb Drug Resist; 2019 Dec; 25(10):1449-1457. PubMed ID: 31237486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends and correlation between antibacterial consumption and carbapenem resistance in gram-negative bacteria in a tertiary hospital in China from 2012 to 2019.
    Liang C; Zhang X; Zhou L; Meng G; Zhong L; Peng P
    BMC Infect Dis; 2021 May; 21(1):444. PubMed ID: 34001022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018.
    Lee YL; Lu MC; Shao PL; Lu PL; Chen YH; Cheng SH; Ko WC; Lin CY; Wu TS; Yen MY; Wang LS; Liu CP; Lee WS; Shi ZY; Chen YS; Wang FD; Tseng SH; Lin CN; Chen YH; Sheng WH; Lee CM; Liao MH; Hsueh PR
    Int J Antimicrob Agents; 2019 Sep; 54(3):318-328. PubMed ID: 31202925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria.
    Nordmann P; Poirel L
    Clin Infect Dis; 2019 Nov; 69(Suppl 7):S521-S528. PubMed ID: 31724045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Ertapenem use with impact assessment on extended-spectrum beta-lactamases (ESBL) production and gram-negative resistance in Singapore General Hospital (SGH).
    Lim CL; Lee W; Lee AL; Liew LT; Nah SC; Wan CN; Chlebicki MP; Kwa AL
    BMC Infect Dis; 2013 Nov; 13():523. PubMed ID: 24195651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warning: spread of NDM-1 in two border towns of Iran.
    Armin S; Fallah F; Azimi L; Samadi Kafil H; Ghazvini K; Hasanzadeh S; Karimi A
    Cell Mol Biol (Noisy-le-grand); 2018 Jul; 64(10):125-129. PubMed ID: 30084804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.